- Home
- GEVO vs ANGO Comparison
GEVO vs ANGO Comparison
Compare GEVO & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- ANGO
- Stock Information
- Founded
- GEVO 2005
- ANGO 1988
- Country
- GEVO United States
- ANGO United States
- Employees
- GEVO N/A
- ANGO N/A
- Industry
- GEVO Major Chemicals
- ANGO Medical/Dental Instruments
- Sector
- GEVO Industrials
- ANGO Health Care
- Exchange
- GEVO Nasdaq
- ANGO Nasdaq
- Market Cap
- GEVO 498.2M
- ANGO 400.8M
- IPO Year
- GEVO 2011
- ANGO 2004
- Fundamental
- Price
- GEVO $2.33
- ANGO $12.29
- Analyst Decision
- GEVO Buy
- ANGO Strong Buy
- Analyst Count
- GEVO 2
- ANGO 3
- Target Price
- GEVO $8.13
- ANGO $19.33
- AVG Volume (30 Days)
- GEVO 6.7M
- ANGO 691.8K
- Earning Date
- GEVO 11-10-2025
- ANGO 10-02-2025
- Dividend Yield
- GEVO N/A
- ANGO N/A
- EPS Growth
- GEVO N/A
- ANGO N/A
- EPS
- GEVO N/A
- ANGO N/A
- Revenue
- GEVO $80,187,000.00
- ANGO $300,718,000.00
- Revenue This Year
- GEVO $909.99
- ANGO $8.18
- Revenue Next Year
- GEVO $11.14
- ANGO $5.15
- P/E Ratio
- GEVO N/A
- ANGO N/A
- Revenue Growth
- GEVO 341.75
- ANGO 2.73
- 52 Week Low
- GEVO $0.92
- ANGO $6.57
- 52 Week High
- GEVO $3.08
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- GEVO 53.10
- ANGO 66.85
- Support Level
- GEVO $2.26
- ANGO $11.42
- Resistance Level
- GEVO $2.54
- ANGO $12.56
- Average True Range (ATR)
- GEVO 0.20
- ANGO 0.43
- MACD
- GEVO -0.03
- ANGO 0.05
- Stochastic Oscillator
- GEVO 19.48
- ANGO 83.47
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.